(P147) Long-Term Outcomes of High-Dose-Rate Interstitial Brachytherapy for Gynecologic Malignancies
April 15th 2014In this study, we perform a single-institution retrospective analysis of outcomes of patients treated with high-dose-rate interstitial brachytherapy (HDR-ISBT) for gynecologic malignancies. Locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and long-term toxicity were evaluated.
(P149) Collimator Design and Optimization for an Ir-192 Based Small-Animal Irradiator
April 15th 2014Small-animal irradiation is a critical part of translational studies in radiation oncology. The ability to deliver a small, highly focused radiation field allows for evaluation of radiation effects, as well as quantification of acute and late toxicities, in an assortment of tissues.
(P143) Advanced Glycation Endproducts: The Sweet Tooth of Radiation Toxicity
April 15th 2014The therapeutic index of treating cancer with ionizing radiation (IR) can be increased by minimizing normal tissue toxicity. Unfortunately, the therapies that have been developed to date have had limited efficacy. Therefore, identifying novel targets to protect normal tissue is essential during treatment.
(P018) Micronucleus Score in Buccal Smear of Premalignant Lesions of Oral Cancers in Smokers
April 15th 2014Oral squamous cell carcinoma encompasses 90% of all oral malignancies. It is considered the sixth most common malignancy and is a major cause of cancer morbidity and mortality worldwide. Early detection of premalignant lesions or cancerous oral lesions would improve the survival to a greater extent.
(P019) Fractionated Robotic Stereotactic Radiosurgery for the Treatment of Benign Meningioma
April 15th 2014Fractionated stereotactic radiosurgery (SRS) may offer several benefits in the treatment of symptomatic or growing meningioma but has not been examined extensively in the literature. Our primary aim was to describe the rates of tumor control and side effects in patients treated with CyberKnife SRS for meningioma.
(P021) Long-Term Survival in Patients With Brain Metastases: Fact or Fallacy?
April 15th 2014A typical patient with a brain metastasis (BM) dies within an average of 8 months following the initial treatment of his or her brain tumor(s). Cause-specific mortality is rarely assessed or recorded, and the BM is often assumed to be the culprit.
(P022) Modern Management of Lymphoepithelioma of the Head and Neck
April 15th 2014Lymphoepithelioma is a rare tumor of the head and neck region, the optimal management of which remains to be defined. We evaluated and report on management outcomes from a large cohort of patients with modern management for this diagnosis.
(P024) Proton Radiotherapy for Midline CNS Lesions: A Class Solution
April 15th 2014Midline and central lesions of the brain requiring conventional radiation therapy (RT) present complex difficulties in dose avoidance to organs at risk (OAR). In either the definitive or adjuvant setting, proper RT coverage of these lesions involves unnecessary treatment of large volumes of normal brain. We propose a class solution for these lesions using proton therapy (PrT).
(P034) Ethnic and Gender Disparities Among Limb Salvage Rates in Pediatric Sarcoma Patients
April 15th 2014Racial and ethnic disparities in limb salvage surgery have been reported among adult sarcoma patients. The purpose of this work was to explore treatment patterns by ethnicity and gender in a cohort of pediatric sarcoma patients.